GlassScriptPhysician profile
Asmita Ahuja
NPI 1053543942
$2,623.11
in general payments reported to CMS, 2019-2025
22 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,885 · 2020: $541 · 2021: $13.34 · 2022: $62.91 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $477.30 | 2019-2021 | |
| Amgen INC. | $468.82 | 2019-2022 | |
| Octapharma USA, INC. | $196.47 | 2019 | |
| Genentech USA, INC. | $168.40 | 2019-2020 | |
| Janssen Biotech, INC. | $143.74 | 2020 | |
| Seagen INC. | $137.28 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $120.79 | 2025 | Lynparza |
| Celgene Corporation | $115.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.75 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $99.00 | 2019 | |
| Genzyme Corporation | $94.71 | 2019 | |
| Merck Sharp & Dohme LLC | $74.57 | 2019-2020 | |
| Incyte Corporation | $70.18 | 2019-2020 | |
| Emd Serono, INC. | $66.34 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $65.02 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $57.97 | 2019 | |
| Rigel Pharmaceuticals, INC. | $49.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.93 | 2019 | |
| Kite Pharma, INC. | $24.92 | 2020 | |
| Eisai INC. | $19.72 | 2020 | |
| Puma Biotechnology, INC. | $11.96 | 2020 | |
| Stemline Therapeutics INC. | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asmita Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.